Quick Summary

Methane SIBO vs. Hydrogen SIBO: The Values and Why the Treatment Changes

When someone searches for “methane SIBO values,” they almost always want two specific things: the number that defines each pattern on the breath test, and why the treatment is not the same depending on the gas. This guide answers both with the figures exactly as they appear in the clinical guidelines, and then explains the context those numbers need so they are not misinterpreted.

Author’s note: I’m not a doctor. I built this site because my sister was diagnosed with SIBO, and while helping her understand her results I ran into something absurd: many Spanish-language pages described “methane vs. hydrogen” without ever stating the specific threshold, which was precisely the data point listed in the lab report. I gathered the values from the original sources here and linked them so anyone can verify them. The goal is for you to walk into your appointment understanding what your report says, not to treat yourself on your own.

The Two Gases and Who Produces Them

The breath test doesn’t see bacteria: it measures exhaled gases after ingesting a substrate (lactulose or glucose) and uses them as an indirect signal of fermentation. The two central gases differ in their origin:

• Hydrogen (H2): produced by bacteria when they ferment carbohydrates. It’s the classic gas of “hydrogen SIBO.”
• Methane (CH4): not produced by bacteria, but by methanogenic archaea, mainly Methanobrevibacter smithii. These archaea consume the hydrogen that bacteria generate and convert it into methane.

This difference in microorganism is the reason recent guidelines and reviews prefer to call the methane pattern IMO (Intestinal Methanogen Overgrowth) rather than “methane SIBO”: archaea are not bacteria, and the overgrowth can be in the small intestine, the colon, or both [1][3].

If you want the general background of the condition, it’s in the guide on what SIBO is. For the details of how the test is done and prepared, the guide on the SIBO breath test lays out all the steps.

The Table With the Values (What the Report Shows)

These are the positivity thresholds of the 2017 North American Consensus (Rezaie et al.), the reference document most laboratories use and that the ACG and AGA guidelines incorporate [1][2][3]:

Aspect	Hydrogen (H2)	Methane / IMO (CH4)
Positive threshold	Rise of 20 ppm or more above baseline within the first 90 min	10 ppm or more at any point during the test (including baseline)
Who produces it	Fermenting bacteria	Methanogenic archaea (M. smithii)
Most associated symptom	Diarrhea, loose stools, urgency	Constipation, slow transit
Typical pattern on the curve	Early, rapid rise in H2	Methane elevated from the start or early; H2 may appear low because the archaea consume it
Response to antibiotics	Usually responds to a single agent	Archaea resist many antibiotics; the literature describes a combination

The key detail that confuses many people is in the last row of “typical pattern”: a low H2 does not mean there is no fermentation. If the archaea are converting that hydrogen into methane, the H2 curve can come out flat while CH4 is elevated. That’s why a methane reading of 10 ppm or more counts as positive even if hydrogen never reached 20.

Why Methane Is Associated With Constipation

Methane isn’t just a passive marker. The North American Consensus itself notes that methane inhibits intestinal transit and that the severity of constipation correlates with the methane level: the more methane, the slower the transit [3]. That’s the physiological basis for why the IMO pattern is associated with constipation and the hydrogen pattern with diarrhea.

“Association” is not “sole cause,” and having constipation does not confirm IMO on its own: diet, hydration, medications (opioids), pelvic floor dysfunction, hypothyroidism, and other factors also play a role. But the methane-constipation relationship is consistent enough to guide the clinical conversation.

A Mini Decision Tree by Gas Pattern

Here’s how the curve is read, step by step, when a professional interprets the report:

1. Does H2 rise 20 ppm or more above baseline before 90 min? → Pattern consistent with hydrogen SIBO. Typical symptom: diarrhea. In the evidence, it usually responds to a non-absorbable antibiotic.

2. Does CH4 reach 10 ppm or more at any point (even if H2 is low)? → Pattern consistent with IMO (methane). Typical symptom: constipation. It requires the specific approach for archaea.

3. Do both rise (H2 of 20 or more and CH4 of 10 or more)? → Mixed pattern. Bacterial and methanogenic fermentation can coexist; management usually covers both.

4. Do both curves come out “flat” despite clear symptoms? → Possible false negative (preparation, transit) or a gas not measured by that test, such as hydrogen sulfide (H2S) (see below).

This tree describes how the result is reasoned through; it does not replace a professional’s reading of the full report alongside your clinical history.

Why the Treatment Changes

Here is the heart of the difference. Hydrogen and methane don’t respond the same way because they aren’t produced by the same type of microorganism.

Hydrogen pattern (bacteria). Bacteria respond to non-absorbable antibiotics. The pharmacological approach described in the guidelines for hydrogen SIBO centers on a single agent. The general framework (without doses) is in the guide on antibiotics and SIBO.

Methane / IMO pattern (archaea). Archaea have a different cell wall and metabolism than bacteria, and they are resistant to most antibiotics [3]. That’s why the literature describes a combination of two antibiotics rather than just one. The most cited study is a retrospective analysis by Low and colleagues in patients with irritable bowel syndrome and positive methane on the lactulose test: the combination of rifaximin plus neomycin eliminated methane in 87% of cases, versus roughly 33% with neomycin alone and 28% with rifaximin alone [4]. It’s worth reading these figures in context: they come from a retrospective study in IBS patients, not from a controlled trial or a guideline consensus, so they indicate a direction (the combination performs better for methane) rather than a universal percentage.

The practical difference comes down to this: with hydrogen the conversation usually revolves around a single antibiotic; with methane, around a combination, precisely because archaea escape a single drug. In both cases there’s a motility component worth reviewing to reduce relapses; that’s covered in the guide on the migrating motor complex.

None of this is a guide to self-treatment. Naming the drugs and the figures is describing what the evidence says, not telling you what to take: the choice, the doses, and the duration are decided by a professional based on your case.

What About Hydrogen Sulfide (H2S)?

H2S is a third gas, frequently associated with diarrhea and intense odors, that some “flat” hydrogen curves could reflect (when bacteria consume the hydrogen to produce H2S). Its measurement is not available in all laboratories, and only some at-home tests include it [5]. You shouldn’t conclude that you have H2S based on odor alone or an atypical curve: it’s a pattern still being characterized and best interpreted with the full report in hand. If you want to go deeper, we have a guide dedicated to hydrogen sulfide (H2S) SIBO.

What Data Make Your Result Interpretable

Before drawing conclusions, these are the points a professional reviews in the report:

• The substrate: lactulose (explores the entire small intestine, with more false positives due to rapid transit) or glucose (more specific to the proximal segment).
• Which gases it measured: hydrogen, methane, and, if available, hydrogen sulfide.
• The baseline: a baseline methane already at 10 ppm or more counts as positive; a high baseline H2 may indicate incomplete preparation.
• The timing of the rise: whether H2 rises before 90 min (small intestine) or only afterward (colon, which is expected and normal).
• The preparation: fasting, the prior diet, and discontinuing whatever the lab specifies, because they alter the baseline.
• Alarm symptoms: weight loss, anemia, blood in the stool, fever, or nighttime diarrhea warrant a separate evaluation.

Closing

If you were looking for the number, here it is: H2 of 20 ppm or more above baseline at 90 minutes and CH4 of 10 ppm or more at any point. And if you were looking for why it matters: because behind hydrogen there are bacteria and behind methane there are archaea, and that biological difference is what makes the management described in the evidence not the same. The value of the test lies in reading that pattern alongside your symptoms and your history, not in isolating it.

Disclaimer: this guide is educational and summarizes public sources; it does not diagnose, treat, or replace medical consultation. If you have a breath test report, take it to a healthcare professional to interpret it alongside your clinical history.

References

1. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165-178. PubMed
2. Quigley EMM, Murray JA, Pimentel M. AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review. Gastroenterology. 2020;159(4):1526-1532. PubMed
3. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2017;112(5):775-784. PMC
4. Low K, Hwang L, Hua J, et al. A Combination of Rifaximin and Neomycin Is Most Effective in Treating Irritable Bowel Syndrome Patients With Methane on Lactulose Breath Test. J Clin Gastroenterol. 2010;44(8):547-550. PubMed
5. Lim J, Rezaie A. Pros and Cons of Breath Testing for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth. Gastroenterol Hepatol (N Y). 2023;19(3):140-146. Gastroenterology & Hepatology